Frontage is a full service CRO which closely collaborates with pharmaceutical and biotech companies to help them bring promising drug candidates to market. With 14 locations in USA and China, Frontage has been assisting clients in their drug development efforts since 2001.
Spanning from preclinical through late-stage development, its full service offerings include DMPK, Bioanalytical Services for Small and Large Molecule and Biomarkers, CMC, Early Stage Clinical Services and Full Biometrics Support.
Frontage also provides turnkey product development services to generic, innovator and consumer health companies to support IND, NDA, ANDA, and 505(b)(2) submissions. What sets us apart is our ability to collaborate closely with our clients to ensure a deep understanding of their drug development goals and our ability provide flexible solutions that are customized to each client’s needs.
At Frontage, we are committed to providing rigorous scientific expertise to ensure the highest quality and compliance on each project. Frontage proudly serves innovator, generic and consumer health companies from IND enabling through late stage clinical projects. Frontage successfully assists clients to advance hundreds of molecules through development to commercial launch in global markets. This partnership with our clients is how we turn services into real solutions that get our clients ahead.